Literature DB >> 9884119

Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety.

S M Weiss1, G Wadsworth, A Fletcher, C T Dourish.   

Abstract

The elevated plus-maze is a commonly used model to identify putative anxiolytic and anxiogenic drugs. However, the validity of elevated plus-maze and other recently developed variants such as the elevated zero-maze has recently been questioned on the grounds that both the reference anxiolytic drug chlordiazepoxide and the psychostimulant d-amphetamine increase open arm exploration and stimulate locomotor activity. These findings suggest that measures of "anxiety" in the elevated maze cannot be adequately dissociated from simple changes in locomotor activity, which may confound the interpretation of results obtained using these models. A variety of approaches to assess drug effects on locomotor activity in the elevated maze have been suggested, including the use of total and closed arm entries, as well as supplementary tests such as exploration of the holeboard apparatus. However, all these approaches utilise the measurement of exploration in a novel environment, and as such, could potentially be influenced by either changes in anxiety or locomotor activity. Recently, it has been shown that ethological measures of "risk assessment", such as stretched-attend postures and head-dipping, are sensitive indicators of drug-effects in the elevated maze. The present study assessed the utility of ethological analysis in dissociating locomotor activity from "anxiety" by comparing the effects of d-amphetamine to those of chlordiazepoxide in the rat elevated zero-maze. The results showed that both chlordiazepoxide and d-amphetamine increase the amount of time spent in the open arms and reduce "risk assessment" without increasing line crossing or rearing. These results confirm that under certain test conditions, psychostimulants are capable of producing "false-positives" in elevated maze models, and that both traditional methods and the ethological measures used in this study fail to unequivocally dissociate drug effects on anxiety from effects on locomotor activity. Further studies using other species and different classes of psychostimulants are warranted to determine the generality of these findings.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9884119     DOI: 10.1016/s0149-7634(98)00027-x

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  41 in total

1.  Gestational vitamin B deficiency leads to homocysteine-associated brain apoptosis and alters neurobehavioral development in rats.

Authors:  Sébastien A Blaise; Emmanuelle Nédélec; Henri Schroeder; Jean-Marc Alberto; Carine Bossenmeyer-Pourié; Jean-Louis Guéant; Jean-Luc Daval
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

2.  Free versus forced exposure to an elevated plus-maze: evidence for new behavioral interpretations during test and retest.

Authors:  Vincent Roy; Pierre Chapillon; Mustapha Jeljeli; Jean Caston; Catherine Belzung
Journal:  Psychopharmacology (Berl)       Date:  2008-11-08       Impact factor: 4.530

3.  Long-term impact of chronic variable stress in adolescence versus adulthood.

Authors:  Evelin M Cotella; Antonela Scarponi Gómez; Paige Lemen; Carrie Chen; Guillermo Fernández; Christian Hansen; James P Herman; María Gabriela Paglini
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-08-07       Impact factor: 5.067

4.  Blockade of the endovanilloid receptor, TRPV1, and of the endocannabinoid enzyme, FAAH, within the nucleus accumbens shell elicits anxiolytic-like effects in male rats.

Authors:  Thibaut R Pardo-García; Nadira Yusif-Rodriguez; Guillermo Yudowski; Carmen S Maldonado-Vlaar
Journal:  Neurosci Lett       Date:  2020-05-16       Impact factor: 3.046

5.  Effect of a selective cyclooxygenase type 2 inhibitor celecoxib on depression associated with obesity in mice: an approach using behavioral tests.

Authors:  Yeshwant Kurhe; Radhakrishnan Mahesh; Deepali Gupta
Journal:  Neurochem Res       Date:  2014-05-11       Impact factor: 3.996

6.  Dose- and time-dependent expression of anxiety-like behavior in the elevated plus-maze during withdrawal from acute and repeated intermittent ethanol intoxication in rats.

Authors:  Zhongqi Zhang; Andrew C Morse; George F Koob; Gery Schulteis
Journal:  Alcohol Clin Exp Res       Date:  2007-09-14       Impact factor: 3.455

7.  The multifaceted effects of oral administration of methylphenidate in juvenile rats: anxiety, activity, and attention.

Authors:  Ning Zhu; Jeremy Weedon; Diana L Dow-Edwards
Journal:  Eur Neuropsychopharmacol       Date:  2010-01-18       Impact factor: 4.600

Review 8.  Animal models of serotonergic psychedelics.

Authors:  James B Hanks; Javier González-Maeso
Journal:  ACS Chem Neurosci       Date:  2012-09-24       Impact factor: 4.418

9.  Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice.

Authors:  Christopher L Kliethermes; Deborah A Finn; John C Crabbe
Journal:  Psychopharmacology (Berl)       Date:  2003-05-29       Impact factor: 4.530

10.  Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus.

Authors:  Yun-Feng Li; Ying Huang; Simon L Amsdell; Lan Xiao; James M O'Donnell; Han-Ting Zhang
Journal:  Neuropsychopharmacology       Date:  2009-06-10       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.